GRI BIO, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
GRI on Nasdaq
Industry
Pharmaceutical Preparations
Location
2223 Avenida De La Playa, Suite 208, La Jolla, California

There are no Buy or Sell transactions made by insiders since 7/18/2023

GRI BIO, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Walter Marc Hertz Chief Executive Officer, Director, 10%+ Owner $1.57 M Apr 21, 2023
Vipin Chaturvedi Chief Scientific Officer $703 K Apr 21, 2023
Albert Agro Chief Medical Officer $703 K Apr 21, 2023
Leanne Kelly Chief Financial Officer $127 K Sep 22, 2023
David Leslie Szekeres Director $52.4 K Aug 10, 2023
Roelof Rongen Director $52.4 K Aug 10, 2023
Camilla V. Simpson Director $52.4 K Aug 10, 2023
David Charles Baker Director $52.4 K Aug 10, 2023
Marella Thorell Director $50.2 K Dec 13, 2022
Ofir Levi Director $45.6 K May 14, 2021
Penny Toren SVP, Regul Affairs & Prog Mgmt $38 K May 14, 2021
Meenu Chhabra Director $22.8 K Feb 23, 2022
Richard Ammer Director $11.4 K Jun 9, 2022
Joseph E. Payne Director $11.4 K Jun 9, 2022

Recent Insider Transactions by Companies or Individuals for GRI BIO, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership